1. Home
  2. BIO vs GMED Comparison

BIO vs GMED Comparison

Compare BIO & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • GMED
  • Stock Information
  • Founded
  • BIO 1952
  • GMED 2003
  • Country
  • BIO United States
  • GMED United States
  • Employees
  • BIO N/A
  • GMED N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • GMED Medical/Dental Instruments
  • Sector
  • BIO Industrials
  • GMED Health Care
  • Exchange
  • BIO Nasdaq
  • GMED Nasdaq
  • Market Cap
  • BIO 8.7B
  • GMED 9.7B
  • IPO Year
  • BIO N/A
  • GMED 2012
  • Fundamental
  • Price
  • BIO $335.27
  • GMED $69.42
  • Analyst Decision
  • BIO Buy
  • GMED Buy
  • Analyst Count
  • BIO 4
  • GMED 12
  • Target Price
  • BIO $369.00
  • GMED $77.36
  • AVG Volume (30 Days)
  • BIO 209.2K
  • GMED 548.0K
  • Earning Date
  • BIO 10-24-2024
  • GMED 11-05-2024
  • Dividend Yield
  • BIO N/A
  • GMED N/A
  • EPS Growth
  • BIO N/A
  • GMED N/A
  • EPS
  • BIO N/A
  • GMED 0.30
  • Revenue
  • BIO $2,562,604,000.00
  • GMED $2,236,530,000.00
  • Revenue This Year
  • BIO N/A
  • GMED $61.37
  • Revenue Next Year
  • BIO $4.49
  • GMED $7.07
  • P/E Ratio
  • BIO N/A
  • GMED $230.82
  • Revenue Growth
  • BIO N/A
  • GMED 103.89
  • 52 Week Low
  • BIO $261.59
  • GMED $43.39
  • 52 Week High
  • BIO $377.88
  • GMED $74.21
  • Technical
  • Relative Strength Index (RSI)
  • BIO 56.82
  • GMED 49.92
  • Support Level
  • BIO $311.04
  • GMED $67.73
  • Resistance Level
  • BIO $333.60
  • GMED $70.85
  • Average True Range (ATR)
  • BIO 8.26
  • GMED 1.30
  • MACD
  • BIO -0.36
  • GMED -0.12
  • Stochastic Oscillator
  • BIO 73.95
  • GMED 50.38

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Share on Social Networks: